Peak6 Investments LLC Cerus Corp Call Options Transaction History

Peak6 Investments LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.83 $22,981 - $39,061	-6,700 Reduced 52.76%	6,000 $22,000
Q2 2022 Aug 12, 2022	BUY	$4.41 - $5.69 $33,957 - $43,813	7,700 Added 154.0%	12,700 $67,000
Q1 2022 May 13, 2022	BUY	$4.81 - $6.99 $24,049 - $34,950	5,000 New	5,000 $27,000
Q2 2021 Aug 13, 2021	SELL	$5.35 - $6.35 $4,815 - $5,715	-900 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.68 - $7.87 $333,984 - $462,756	-58,800 Reduced 98.49%	900 $5,000
Q4 2020 Feb 12, 2021	BUY	$5.25 - $8.56 $193,200 - $315,008	36,800 Added 160.7%	59,700 $413,000
Q1 2020 May 14, 2020	BUY	$2.87 - $5.49 $31,570 - $60,390	11,000 Added 92.44%	22,900 $106,000
Q4 2019 Feb 13, 2020	SELL	$3.84 - $4.86 $21,888 - $27,702	-5,700 Reduced 32.39%	11,900 $50,000
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $90,816 - $120,560	17,600 New	17,600 $110,000
Q4 2018 Feb 13, 2019	SELL	$4.89 - $7.16 $67,482 - $98,808	-13,800 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.89 - $7.78 $95,082 - $107,364	13,800 New	13,800 $99,000

155

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $280M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.